Network-based approach to identify biomarkers predicting response and prognosis for HER2-negative breast cancer treatment with taxane-anthracycline neoadjuvant chemotherapyCui Jiang, Tao Sun, Lei Jiang et al.|PeerJ|2019Cited by 18